Literature DB >> 11777269

Human embryonic stem cells: culture, differentiation, and genetic modification for regenerative medicine applications.

J S Lebkowski1, J Gold, C Xu, W Funk, C P Chiu, M K Carpenter.   

Abstract

Human embryonic stem (hES) cells can proliferate extensively in culture and can differentiate into representatives of all three embryonic germ layers in vitro and in vivo. The undifferentiated hES cells have now been cultured for more than 50 passages in vitro, yet maintain a normal karyotype. The hES cells express a series of specific surface antigens, as well as OCT-4 and human telomerase, proteins associated with a pluripotent and immortal phenotype. On differentiation, OCT-4 and human telomerase expression decreases with the emergence of a maturing population of cells. During hES cell differentiation, modulation of the expression of many genes has been evaluated using microarray analysis. To improve the ease, reproducibility, and scalability of hES culture, methods have been developed to propagate the cells in the absence of mouse embryonic cell feeders. hES cells maintained in culture using extracellular matrix factors together with mouse embryonic cell conditioned medium proliferate indefinitely while maintaining a normal karyotype, proliferation rate, and complement of undifferentiated cell markers. hES cells cultured without feeder layers retain their capacity to differentiate into cells of all three germ layers in vitro and in teratomas. The hES cells can also be genetically modified transiently or stably using both plasmid and viral gene transfer agents. These analyses and technological developments will aid in the realization of the full potential of hES cells for both research and therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11777269

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  15 in total

1.  Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells.

Authors:  J Kim; Y Lee; H Kim; K J Hwang; H C Kwon; S K Kim; D J Cho; S G Kang; J You
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

2.  Application of methods for viral clearance in stem cell production.

Authors:  Fernando Cobo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-10-13       Impact factor: 2.416

3.  Stem cells: From embryology to cellular therapy? An appraisal of the present state of art.

Authors:  Sandro Eridani; Vittorio Sgaramella; Lidia Cova
Journal:  Cytotechnology       Date:  2004-03       Impact factor: 2.058

4.  Minimization of exogenous signals in ES cell culture induces rostral hypothalamic differentiation.

Authors:  Takafumi Wataya; Satoshi Ando; Keiko Muguruma; Hanako Ikeda; Kiichi Watanabe; Mototsugu Eiraku; Masako Kawada; Jun Takahashi; Nobuo Hashimoto; Yoshiki Sasai
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

5.  Enhanced transfection efficiency of human embryonic stem cells by the incorporation of DNA liposomes in extracellular matrix.

Authors:  Luis G Villa-Diaz; Jose L Garcia-Perez; Paul H Krebsbach
Journal:  Stem Cells Dev       Date:  2010-09-29       Impact factor: 3.272

Review 6.  Human embryonic stem cells: potential tool for achieving immunotolerance?

Authors:  Pablo Menendez; Clara Bueno; Lisheng Wang; Mickie Bhatia
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

7.  Proliferation of adult human bronchial epithelial cells without a telomere maintenance mechanism for over 200 population doublings.

Authors:  Jennifer R Peters-Hall; Jaewon Min; Enzo Tedone; Sei Sho; Silvia Siteni; Ilgen Mender; Jerry W Shay
Journal:  FASEB J       Date:  2019-11-22       Impact factor: 5.191

Review 8.  Lessons from human teratomas to guide development of safe stem cell therapies.

Authors:  Justine J Cunningham; Thomas M Ulbright; Martin F Pera; Leendert H J Looijenga
Journal:  Nat Biotechnol       Date:  2012-09       Impact factor: 54.908

Review 9.  Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges.

Authors:  Yongjia Fan; Jincheng Wu; Preeti Ashok; Michael Hsiung; Emmanuel S Tzanakakis
Journal:  Stem Cell Rev Rep       Date:  2015-02       Impact factor: 5.739

10.  Aspects on properties, use and ethical considerations of embryonic stem cells - A short review.

Authors:  Ole Johan Borge; Kathinka Evers
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.